• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,499.17 129.78
(0.25%)
Dow Jones
7,562.80 59.09
(0.79%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Astal Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
512600
INE307N01014
76.1385762
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
44.41
359.81
EPS(TTM)
Face Value()
Div & Yield %
1.85
10
0
 

Hardwyn India consolidated net profit rises 84.41% in the March 2026 quarter
Jun 01,2026
Net profit of Hardwyn India rose 84.41% to Rs 3.43 crore in the quarter ended March 2026 as against Rs 1.86 crore during the previous quarter ended March 2025. Sales rose 25.22% to Rs 57.15 crore in the quarter ended March 2026 as against Rs 45.64 crore during the previous quarter ended March 2025.

For the full year,net profit rose 17.63% to Rs 13.21 crore in the year ended March 2026 as against Rs 11.23 crore during the previous year ended March 2025. Sales rose 8.27% to Rs 199.86 crore in the year ended March 2026 as against Rs 184.60 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales57.1545.64 25 199.86184.60 8
OPM %10.016.53 -10.619.77 -
PBDT5.553.08 80 20.6517.61 17
PBT5.042.63 92 18.8115.85 19
NP3.431.86 84 13.2111.23 18